Bladder Cancer - Results from #20

Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients. January 20, 2023

Neoadjuvant Gemcitabine-Carboplatin Versus Gemcitabine-Cisplatin in Patients with Muscle-Invasive Bladder Cancer - Expert Commentary January 19, 2023

Feasibility of Early Evaluation for the Recurrence of Bladder Cancer after Trans-Urethral Resection: A Comparison between Magnetic Resonance Imaging and Multidetector Computed Tomography. January 19, 2023

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review. January 19, 2023

Theranostic targeting of CUB domain containing protein 1 (CDCP1) in multiple subtypes of bladder cancer. January 19, 2023

Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study. January 18, 2023

The Association Between the Urinary Microbiome and Bladder Cancer. January 18, 2023

Integrated DNA and RNA Sequencing of Advanced Urothelial Cancers - Expert Commentary January 17, 2023

Performance of CellDetect for detection of bladder cancer: Comparison with urine cytology and UroVysion. January 17, 2023

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. January 17, 2023

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. January 16, 2023

KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer. January 16, 2023

Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit for bladder cancer in an ERAS setup (BORARC): protocol for a single-centre, double-blinded, randomised feasibility January 16, 2023

Association of smoking history on health-related quality of life in patients undergoing radical cystecomy. January 13, 2023

Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials. January 13, 2023

The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer. January 12, 2023

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors. January 12, 2023

Avelumab and Talazoparib Treatment in Patients with Advanced Urothelial Cancer - Expert Commentary January 11, 2023

How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience. January 11, 2023

Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer. January 11, 2023

Page 2 of 453

email news signup